|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||3.75 / 10.06|
Other movers include Incyte, Achillion and Inovio.
Cytokinetics, Achillion and Qiagen were among the biotech stock movers in premarket trading on Thursday.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Achillion Pharmaceuticals Inc. , where a total volume of 6,467 contracts has been traded thus far today, a contract volume which is representative of approximately 646,700 underlying shares (given that every 1 contract represents 100 underlying shares).
It's reaching a high level, which is reason for concern about how much longer this rally will run.
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
The healthcare sector was dragged down by reports of price collusion and worse-than-expected third-quarter profits.
The American Society of Hematology (ASH) annual meeting is one of the most important medical conferences held each year, focusing on new drugs to treat blood-related diseases, including blood cancers.
Our screen reveals 17 names that could become oversold and disconnected from their fundamentals as a result of this phenomenon.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Investors in Achillion Pharmaceuticals Inc. saw new options begin trading this week, for the June 2017 expiration.
Investors in Achillion Pharmaceuticals Inc. saw new options become available this week, for the November 18th expiration.
ePoster presentation to detail study results including SVR12 for eight and six week triplet regimen and eight week doublet regimen
Investors in Achillion Pharmaceuticals Inc. saw new options begin trading today, for the August 26th expiration.
Achillion Pharmaceuticals (ACHN) stock rating was increased this morning to 'market outperform' at JMP as the firm believes the company's factor D program is a 'game changer.'